News - Latest
96 news items
The MEB in 2018: A focus on core tasks
'At the MEB life is never boring'. This is how MEB chair Ton de Boer and director Hugo Hurts start their review of 2018. This ...
Science Magazine, 7th edition: Rapid developments in advanced therapies and the vision for Regulatory Science 2025
The MEB, the Dutch medicines authority, publishes the seventh edition of its Regulatory Science Magazine today. This edition ...
Brexit: Notification by the European Commission/EMA/CMDh and CMDv about Brexit and EU rules for batch control of medicinal products
On 25 February 2019 the European Commission (EC) published a notice on the European rules for batch control testing of medicinal ...
MEB fee rate change as of January 2019
The Medicines Evaluation Board (MEB) is increasing the fee rates for authorisation applications, authorisation changes and the ...
Items on the launch of the MEB Academy and improvements in paediatric medicines in MEB Regulatory Science Magazine
The 6th issue of the Medicines Evaluation Board’s Regulatory Science Magazine is published today. This edition is devoted to the ...
Minister Bruno Bruins launches initiative for more reliable, easier-to-find information on medicines
Patients need reliable and comprehensible information on medicines that is easier to find online. In order to achieve this, Bruno ...
New layout of the MEB website
Starting today, the website of the Medicines Evaluation Board (MEB) has a new layout. This makes the website more user-friendly ...
Year-end withdrawals
Requests for withdrawal on December 31st (the year-end withdrawals) should be received by the Medicines Evaluation Board (MEB) on ...
MEB and Swissmedic sign Memorandum of Understanding
The Medicines Evaluation Board (MEB) intends to intensify collaboration with its partner authority in Switzerland in the field of ...
Brexit: fully prepared
The United Kingdom (UK) is leaving the European Union. The terms on which the UK is going to leave the EU are still unclear. The ...